Literature DB >> 16631017

Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of heart failure: the Glucose-Insulin-Potassium Study (GIPS)-II.

Jorik R Timmer, Tone Svilaas, Jan Paul Ottervanger, Jose P S Henriques, Jan-Henk E Dambrink, Stan A J van den Broek, Iwan C C van der Horst, Felix Zijlstra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16631017     DOI： 10.1016/j.jacc.2006.01.040

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  15 in total

Review 1.  Glycemic variability and glycemic control in the acutely ill cardiac patient.

Authors:  Jared Moore; Kathleen Dungan
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

2.  One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial).

Authors:  Harry P Selker; James E Udelson; Joseph M Massaro; Robin Ruthazer; Ralph B D'Agostino; John L Griffith; Patricia R Sheehan; Patrice Desvigne-Nickens; Yves Rosenberg; Xin Tian; Ellen M Vickery; James M Atkins; Tom P Aufderheide; Assaad J Sayah; Ronald G Pirrallo; Michael K Levy; Michael E Richards; Darren A Braude; Delanor D Doyle; Ralph J Frascone; Donald J Kosiak; James M Leaming; Carin M Van Gelder; Gert-Paul Walter; Marvin A Wayne; Robert H Woolard; Joni R Beshansky
Journal:  Am J Cardiol       Date:  2014-03-01       Impact factor: 2.778

3.  Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.

Authors:  Harry P Selker; Joni R Beshansky; Patricia R Sheehan; Joseph M Massaro; John L Griffith; Ralph B D'Agostino; Robin Ruthazer; James M Atkins; Assaad J Sayah; Michael K Levy; Michael E Richards; Tom P Aufderheide; Darren A Braude; Ronald G Pirrallo; Delanor D Doyle; Ralph J Frascone; Donald J Kosiak; James M Leaming; Carin M Van Gelder; Gert-Paul Walter; Marvin A Wayne; Robert H Woolard; Lionel H Opie; Charles E Rackley; Carl S Apstein; James E Udelson
Journal:  JAMA       Date:  2012-03-27       Impact factor: 56.272

4.  A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction.

Authors:  Mamas A Mamas; Ludwig Neyses; Farzin Fath-Ordoubadi
Journal:  Exp Clin Cardiol       Date:  2010

5.  How to manage hyperglycemia in an acute coronary syndrome patient.

Authors:  David Vivas; Esther Bernardo; Julian Palacios-Rubio; Antonio Fernández-Ortiz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-02

Review 6.  Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points.

Authors:  Abhinav Goyal; Kara Nerenberg; Hertzel C Gerstein; Guillermo Umpierrez; Peter W F Wilson
Journal:  Diab Vasc Dis Res       Date:  2008-11       Impact factor: 3.291

Review 7.  Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction.

Authors:  Antonio Rodríguez-Sinovas; Yaser Abdallah; Hans Michael Piper; David Garcia-Dorado
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

8.  Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.

Authors:  Muneaki Matsubara; Shinya Kanemoto; Bradley G Leshnower; Earl F Albone; Robin Hinmon; Theodore Plappert; Joseph H Gorman; Robert C Gorman
Journal:  J Surg Res       Date:  2009-04-16       Impact factor: 2.192

9.  Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction.

Authors:  Iwan C C van der Horst; Maarten W N Nijsten; Mathijs Vogelzang; Felix Zijlstra
Journal:  Cardiovasc Diabetol       Date:  2007-02-06       Impact factor: 9.951

10.  Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics.

Authors:  Anjan K Chakrabarti; Priyamvada Singh; Lakshmi Gopalakrishnan; Varun Kumar; Meagan Elizabeth Doherty; Cassandra Abueg; Weici Wang; C Michael Gibson
Journal:  Cardiol Res Pract       Date:  2012-07-09       Impact factor: 1.866
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.